Always consult with your healthcare provider before starting any new treatment
Comment: The applicant requested that CMS withdraw C1739, the device category code established upon the preliminary approval of the SCOUT MD TM Delivery System application for device pass-through payment status and issue a new HCPCS code with descriptor language including, radar detectable implantable reflectors, effective January 1, 2026, to ensure that the SCOUT MD TM Delivery System receives the full 3 years of pass-through status
I didn't even think about that as being the root cause behind of all this
Acknowledgments We thank Amelia K
It's taken orally , not via injection, and it has no known toxicity or adverse effects
Peptide blends can reduce preparation time, improve workflow efficiency, and help maintain ingredient consistency across studies